直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit Rules on Broadening Reissues, Joint Inventorship, and Intervening Rights

April 19, 2012

Webinar

Keeping up with the growing body of case law is a must for IP lawyers. Federal Circuit decisions can impact a company’s IP portfolio strategy on many levels and in significant or subtle ways. Some decisions are of particular importance and well worth a closer look.

Please join our panelists as they discuss:

In re Staats

• Considered whether an applicant can add broadened claims in a continuing reissue application filed outside section 251’s two-year limit

• Held that because Staats timely filed an original broadening reissue application within the two-year limit, he was not barred from seeking broadened continuation reissue claims even though they were directed to subject matter different from the original reissue application

Falana v. Kent State University

• Considered whether a researcher who creates a method of making a new class of chemical compounds should be named as a co-inventor of claims directed to the compounds themselves

• Held that discovery of the method is as much a contribution to the compounds as the discovery of the compounds themselves, requiring the creator of the method to be named as a co-inventor

Marine Polymer v. HemCon, Inc. (en banc)

• Considered whether a patentee’s arguments made during ex parte reexamination can give rise to intervening rights under 35 U.S.C. § 307(b) when the patent claims in question are not changed during the reexamination

• Held that intervening rights apply only to “amended or new” claims incorporated into a patent during reexamination

The analysis and discussion will be led by seasoned Federal Circuit practitioners Michael J. Flibbert and Kara F. Stoll. Mike has successfully represented clients in patent disputes before the Federal Circuit involving technologies such as pharmaceuticals, biotechnology, and chemistry. Kara has represented clients in over thirty appeals to the Federal Circuit, primarily focusing on consumer electronics, computer, software, and the medical device industries. As former court clerks, both Mike and Kara have gained experience at the Federal Circuit from multiple perspectives.

This webinar is the second in our 2012 Federal Circuit webinar series. We hope you are able to attend.





Speakers


Michael J. Flibbert

Kara F. Stoll



Time


1:00 - 2:00 p.m. EDT

Register

There is no charge to attend this program. Please register by April 16, 2012. Webinar access and dial-in information will be sent upon registration.

Downloadable Files

  • Federal Circuit Rules on Broadening Reissues, Joint Inventorship, and Intervening Rights

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Professionals

Michael J. Flibbert
Partner
Washington, DC
+1 202 408 4493
Email

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP